April 14, 2025

FDA-Approved COVID-19 Drugs: Safety Risks Assessed

Researchers found most FDA-authorized COVID-19 treatments were not linked to serious adverse events, though risks may rise with tocilizumab or convalescent plasma in specific patients.

Conexiant

April 11, 2025

Higher Arsenic in Brown Rice Poses Risk to Children

Research reveals brown rice contains significantly more inorganic arsenic than white rice, with exposure levels potentially exceeding safety thresholds for young children under 5 years old.

Conexiant

April 10, 2025

FDA to Pilot Animal-Free Models

"This initiative marks a paradigm shift in drug evaluation and holds promise to accelerate cures and meaningful treatments for Americans while reducing animal use."

Reuters

April 10, 2025

Medical Oddities: Chewing Gum to Fight Flu & Herpes

Gum that fights viruses, tea that tames tumors, and grip strength that beats your DNA—science is getting creative (and tasty) this week.

Conexiant

April 10, 2025

Morning Coffee Consumption Linked to Lower Mortality Risk

“Drinking coffee in the morning may be more strongly associated with a lower risk of mortality than drinking coffee later in the day."

Conexiant

April 09, 2025

Dual Immunotherapy Approved for Advanced CRC

The FDA approved nivolumab with ipilimumab for unresectable or metastatic microsatellite instability–high or mismatch repair–deficient colorectal cancer.

Conexiant

April 07, 2025

My View: My journey with oral cancer awareness

Parul Dua Makkar, D.D.S., describes losing her brother to oral cancer and what dentists can do to help detect the disease.

ADA News

April 04, 2025

Gram-Negative Infection: 7 vs 14 Days of Antibiotics

Mortality occurred in 12.8% of the patients in the 7-day group compared with 13.7% of those in the 14-day group.

Conexiant

April 03, 2025

Lung Screening Lags Despite Cancer Prevention Uptake

Eligible patients undergo breast and colorectal cancer screenings at nearly four times the rate of recommended lung cancer screening, revealing significant intervention opportunities, according to a new JAMA study.

Conexiant